In Japan, the PCSK9 gain‐of‐function NM_174936.3(PCSK9): c.94G>A variant is reported to affect ~6% of heterozygous FH subjects and is possibly more common due to a founder gene effect (Mabuchi et al., 2014). Here, PCSK9 is linked to familial hyperaldosteronism.